Medical specialists from India tagged as investigators in clinical trials studying Hepatitis

Total 22 results

Abhijit Chowdhury
Seen in:
- West Bengal, Kolkata, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Alben Sigamani, MD
Seen in:
- Karnataka, Bangalore, Mazumdar Shaw Mutispeciality Hospital
Trials:
- NCT02899130 (Principal Investigator)
Conditions:
- Chronic Hepatitis B
Alisha Chaubal
Seen in:
- Maharashtra, Mumbai, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Anil Arora, M.D
Seen in:
- New Delhi, Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital
Trials:
- NCT01866072 (Principal Investigator)
Conditions:
- Acute on Chronic Liver Failure;
- Acute Severe Viral Hepatitis
Dharmesh Kapoor
Seen in:
- Secunderabad, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions:
Ganesh Subramanian
Seen in:
- Chennai, GSK Investigational Site
- Tamil Nadu, Chennai, Apollo Speciality Hospital - Teynampet
Trials:
- NCT04232553 (Principal Investigator)
- NCT05630820 (Principal Investigator)
Conditions:
Kaivan Shah
Seen in:
- Gujarat, Ahmedabad, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Kumar K Singh, MD
Seen in:
- Delhi, New Delhi, All India Institute of Medical Sciences
Trials:
- NCT00689546 (Sub-Investigator)
Conditions:
- Diabetes Mellitus;
- Acute Viral Hepatitis
Madhu Gupta, MD
Seen in:
- UT, Chandigarh, School of Public Health, Post Graduate Institute of Medical Education and Research
Trials:
- NCT00877357 (Principal Investigator)
Conditions:
- Hepatitis B;
- Pertussis;
- Tetanus;
- Diphtheria;
- Haemophilus Influenzae Type B
Manas Mondal
Seen in:
- Kolkata, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Manoj Lahoti
Seen in:
- Chhattisgarh, Raipur, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Meghraj Ingle
Seen in:
- Maharashtra, Mumbai, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Neeraj Saraf
Seen in:
- Haryana, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Nitin V Pai
Seen in:
- Pune, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Praveen Sharma
Seen in:
- New Delhi, Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital
- New Delhi, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT01866072 (Sub-Investigator)
Conditions:
Shalimar NA
Seen in:
- New Delhi, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Shine Sadasivan
Seen in:
- Kochi, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Shiv Kumar Sarin
Seen in:
- New Delhi, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions:
Shrikant Vasantrao Mukewar
Seen in:
- Nagpur, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions:
Subrat K Acharya, DM
Seen in:
- Delhi, AII India Institute of Medical Sciences
- Delhi, All India Institute of Medical Sciences
- Delhi, New Delhi, AII India Institute of Medical Sciences
Trials:
- NCT02240771 (Principal Investigator)
- NCT01698723 (Principal Investigator)
Conditions:
Vinay Kumar
Seen in:
- Kanpur, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic

Clinical Trials on Hepatitis

National Taiwan University Hospital
National Science Council, Taiwan; National Health Research Institutes, Taiwan

Unknown

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

Chronic Hepatitis B | Chronic Hepatitis D

Taiwan
University of Maryland, Baltimore
Alexandria University; MADAUS GmbH; The Egyptian Company for Blood Transfusion... and other collaborators

Terminated

Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis

Acute Hepatitis C | Acute Hepatitis B | Acute Hepatitis A | Acute Hepatitis E | Acute EBV Hepatitis | Acute CMV Hepatitis

Egypt
Gilead Sciences

Completed

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Chronic Hepatitis Delta

France, Moldova, Republic of, Romania, Russian Federation
Ziauddin Hospital

Unknown

Ezetimibe for Patients With Chronic Hepatitis D

Chronic Hepatitis D

Pakistan
Hepatera Ltd.

Completed

Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection

Chronic Hepatitis D Infection
AbbVie

Completed

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

Chronic Hepatitis C | Hepatitis C (HCV) | Hepatitis C Genotype 1a
AbbVie (prior sponsor, Abbott)

Completed

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Chronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV)

United States, Australia, Canada, France, Germany, New Zealand, Puerto Rico, Spain, United Kingdom
PharmaEssentia

Recruiting

The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Chronic Hepatitis B Infection | Chronic Hepatitis D Infection

Taiwan
Hepatera Ltd.
Data Matrix Solutions

Completed

A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D

Chronic Hepatitis D Infection With Hepatitis B

Russian Federation, Germany
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection (CERTAIN-2)

Hepatitis C Virus | Chronic Hepatitis C Virus

Medical specialists from India tagged as investigators in clinical trials studying Hepatitis

Clinical Trials on Hepatitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations